Home Stock

Stock Research: CVS Group

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

CVS Group

AIM:CVSG GB00B2863827
46
  • Value
    30
  • Growth
    37
  • Safety
    Safety
    41
  • Combined
    18
  • Sentiment
    90
  • 360° View
    360° View
    46
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

CVS Group plc provides veterinary services; it operates in Veterinary Practices, Laboratories, and Online Retail Business, with brands like Animed Direct, MiPet, and EqueVet-Pro. It has operations in the United Kingdom and Australia. In the last fiscal year, the company had 8822 employees, a market cap of $1173 millions, profits of $351 millions, and revenue of $818 millions.

more
Strongest Rank Capital Growth
Weakest Rank Pro Holdings
Country United Kingdom
Industry Health Care Facilities
Size Small
Website cvsukltd.co.uk
Index
CVS Group stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 52 28 39
Growth
37 10 5 39
Safety
Safety
41 51 58 37
Sentiment
90 20 46 65
360° View
360° View
46 9 16 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
73 63 81 65
Opinions Change
81 31 10 50
Pro Holdings
n/a 18 48 15
Market Pulse
48 35 67 80
Sentiment
90 20 46 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 52 28 39
Growth
37 10 5 39
Safety Safety
41 51 58 37
Combined
18 26 12 22
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
66 78 57 52
Price vs. Earnings (P/E)
46 57 51 58
Price vs. Book (P/B)
23 41 12 28
Dividend Yield
43 47 30 35
Value
30 52 28 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
42 25 43 34
Profit Growth
53 20 31 23
Capital Growth
1 75 9 36
Stock Returns
87 8 31 87
Growth
37 10 5 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
38 31 50 36
Refinancing
27 34 35 25
Liquidity
41 54 50 34
Safety Safety
41 51 58 37

Similar Stocks

Discover high‑ranked alternatives to CVS Group and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Quilter

LSE:QLT
Country: United Kingdom
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Carl Zeiss Meditec

XTRA:AFX
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

Only the professional market sentiment is positive. The stock is expensive, has low growth, and low financial safety. This is a weak investment proposition. Only a small, highly-speculative investment may be justified by investors who strongly believe the positive sentiment points to an positive future.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews